Decreasing Risk of Breast Cancer Recurrence Aided by Good Bone Health

2012 June 11

Good bone health may also be a step towards preventing recurrence of breast cancer, according to results from an exploratory study led by the NCIC Clinical Trials Group (NCIC CTG) located at Queen's University.

"Results of the study suggest that preventing this deterioration in bone health by using commonly-used therapeutics known as bisphosphonates may have an additional positive effect in decreasing the risk of breast cancer recurrence", says Lois Shepherd, Professor in the Department of Pathology and Molecular Medicine at Queen's University, physician coordinator at the NCIC Clinical Trials Group and a pathologist at Kingston General Hospital.